Literature DB >> 28984872

p53 shades of Hippo.

Noa Furth1, Yael Aylon1, Moshe Oren1.   

Abstract

The three p53 family members, p53, p63 and p73, are structurally similar and share many biochemical activities. Yet, along with their common fundamental role in protecting genomic fidelity, each has acquired distinct functions related to diverse cell autonomous and non-autonomous processes. Similar to the p53 family, the Hippo signaling pathway impacts a multitude of cellular processes, spanning from cell cycle and metabolism to development and tumor suppression. The core Hippo module consists of the tumor-suppressive MST-LATS kinases and oncogenic transcriptional co-effectors YAP and TAZ. A wealth of accumulated data suggests a complex and delicate regulatory network connecting the p53 and Hippo pathways, in a highly context-specific manner. This generates multiple layers of interaction, ranging from interdependent and collaborative signaling to apparent antagonistic activity. Furthermore, genetic and epigenetic alterations can disrupt this homeostatic network, paving the way to genomic instability and cancer. This strengthens the need to better understand the nuances that control the molecular function of each component and the cross-talk between the different components. Here, we review interactions between the p53 and Hippo pathways within a subset of physiological contexts, focusing on normal stem cells and development, as well as regulation of apoptosis, senescence and metabolism in transformed cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28984872      PMCID: PMC5729527          DOI: 10.1038/cdd.2017.163

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  186 in total

1.  The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex.

Authors:  Min Sup Song; Su Jung Song; So Yeon Kim; Hyun Jung Oh; Dae-Sik Lim
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

2.  Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling.

Authors:  Jackie Wanjala; Barry S Taylor; Caren Chapinski; Haley Hieronymus; John Wongvipat; Yu Chen; Gouri J Nanjangud; Nikolaus Schultz; Yingqiu Xie; Shenji Liu; Wenfu Lu; Qing Yang; Chris Sander; Zhenbang Chen; Charles L Sawyers; Brett S Carver
Journal:  Mol Cancer Ther       Date:  2014-11-07       Impact factor: 6.261

Review 3.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

4.  Tumor suppressor RASSF1A promoter: p53 binding and methylation.

Authors:  Yihao Tian; Yu Hou; Xiang Zhou; Hanhua Cheng; Rongjia Zhou
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

5.  p53 Activation in adipocytes of obese mice.

Authors:  Naoya Yahagi; Hitoshi Shimano; Takashi Matsuzaka; Yuho Najima; Motohiro Sekiya; Yoshimi Nakagawa; Tomohiro Ide; Sachiko Tomita; Hiroaki Okazaki; Yoshiaki Tamura; Yoko Iizuka; Ken Ohashi; Takanari Gotoda; Ryozo Nagai; Satoshi Kimura; Shun Ishibashi; Jun-Ichi Osuga; Nobuhiro Yamada
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

6.  The E3 ubiquitin ligase Itch controls the protein stability of p63.

Authors:  Mario Rossi; Rami I Aqeilan; Michael Neale; Eleonora Candi; Paolo Salomoni; Richard A Knight; Carlo M Croce; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

7.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Authors:  Toshiro Moroishi; Hyun Woo Park; Baodong Qin; Qian Chen; Zhipeng Meng; Steven W Plouffe; Koji Taniguchi; Fa-Xing Yu; Michael Karin; Duojia Pan; Kun-Liang Guan
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

8.  Curcumin enhances temsirolimus-induced apoptosis in human renal carcinoma cells through upregulation of YAP/p53.

Authors:  Shan Xu; Zheng Yang; Yizeng Fan; Bing Guan; Jing Jia; Yang Gao; Ke Wang; Kaijie Wu; Xinyang Wang; Pengsheng Zheng; Dalin He; Peng Guo
Journal:  Oncol Lett       Date:  2016-11-10       Impact factor: 2.967

9.  Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation.

Authors:  Y Aylon; N Yabuta; H Besserglick; Y Buganim; V Rotter; H Nojima; M Oren
Journal:  Oncogene       Date:  2009-10-26       Impact factor: 9.867

Review 10.  The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Annu Rev Biochem       Date:  2016-05-04       Impact factor: 23.643

View more
  40 in total

1.  PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.

Authors:  Chengyuan Dong; Wenhua Fan; Sheng Fang
Journal:  J Mol Neurosci       Date:  2019-10-15       Impact factor: 3.444

Review 2.  Skin immunity and its dysregulation in psoriasis.

Authors:  Caterina Lanna; Mara Mancini; Roberta Gaziano; Maria Vittoria Cannizzaro; Marco Galluzzo; Marina Talamonti; Valentina Rovella; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Ying Wang; Yufang Shi; Elena Campione; Luca Bianchi
Journal:  Cell Cycle       Date:  2019-08-15       Impact factor: 4.534

3.  Multi-omics profiling of calcium-induced human keratinocytes differentiation reveals modulation of unfolded protein response signaling pathways.

Authors:  Anna Michaletti; Mara Mancini; Artem Smirnov; Eleonora Candi; Gerry Melino; Lello Zolla
Journal:  Cell Cycle       Date:  2019-07-22       Impact factor: 4.534

Review 4.  Context is everything: extrinsic signalling and gain-of-function p53 mutants.

Authors:  Ivano Amelio; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-23

Review 5.  The role of noncoding RNAs in epithelial cancer.

Authors:  Massimiliano Agostini; Carlo Ganini; Eleonora Candi; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-12

Review 6.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

Review 7.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

Review 8.  Interplay between HMGA and TP53 in cell cycle control along tumor progression.

Authors:  Nathalia Meireles Da Costa; Antonio Palumbo; Marco De Martino; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Cell Mol Life Sci       Date:  2020-09-12       Impact factor: 9.261

9.  Transcriptional profiling reveals a subset of human breast tumors that retain wt TP53 but display mutant p53-associated features.

Authors:  Gal Benor; Garold Fuks; Suet-Feung Chin; Oscar M Rueda; Saptaparna Mukherjee; Sharathchandra Arandkar; Yael Aylon; Carlos Caldas; Eytan Domany; Moshe Oren
Journal:  Mol Oncol       Date:  2020-06-23       Impact factor: 6.603

Review 10.  Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.

Authors:  Elena Campione; Caterina Lanna; Laura Diluvio; Maria Vittoria Cannizzaro; Sandro Grelli; Marco Galluzzo; Marina Talamonti; Margherita Annicchiarico-Petruzzelli; Mara Mancini; Gerry Melino; Eleonora Candi; Gianfranco Schiavone; Ying Wang; Yufang Shi; Luca Bianchi
Journal:  Cell Cycle       Date:  2020-01-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.